Integra LifeSciences Holdings EBITDA Margin 2012-2026 | IART
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current EBITDA margin for Integra LifeSciences Holdings as of June 30, 2026 is .
| Integra LifeSciences Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-06-30 | $1.65B | $0.22B | 13.53% |
| 2026-03-31 | $1.65B | $-0.31B | -18.72% |
| 2025-12-31 | $1.64B | $-0.34B | -20.54% |
| 2025-09-30 | $1.64B | $-0.32B | -19.65% |
| 2025-06-30 | $1.62B | $-0.35B | -21.32% |
| 2025-03-31 | $1.63B | $0.16B | 9.97% |
| 2024-12-31 | $1.61B | $0.18B | 10.86% |
| 2024-09-30 | $1.57B | $0.17B | 10.73% |
| 2024-06-30 | $1.57B | $0.20B | 12.64% |
| 2024-03-31 | $1.53B | $0.21B | 13.60% |
| 2023-12-31 | $1.54B | $0.24B | 15.64% |
| 2023-09-30 | $1.54B | $0.27B | 17.64% |
| 2023-06-30 | $1.55B | $0.31B | 20.00% |
| 2023-03-31 | $1.56B | $0.36B | 22.73% |
| 2022-12-31 | $1.56B | $0.36B | 23.36% |
| 2022-09-30 | $1.57B | $0.36B | 22.73% |
| 2022-06-30 | $1.57B | $0.35B | 22.19% |
| 2022-03-31 | $1.56B | $0.34B | 21.79% |
| 2021-12-31 | $1.54B | $0.32B | 21.00% |
| 2021-09-30 | $1.53B | $0.32B | 20.84% |
| 2021-06-30 | $1.51B | $0.33B | 21.74% |
| 2021-03-31 | $1.38B | $0.29B | 21.34% |
| 2020-12-31 | $1.37B | $0.30B | 21.50% |
| 2020-09-30 | $1.38B | $0.28B | 19.96% |
| 2020-06-30 | $1.39B | $0.19B | 13.34% |
| 2020-03-31 | $1.51B | $0.21B | 13.89% |
| 2019-12-31 | $1.52B | $0.21B | 13.70% |
| 2019-09-30 | $1.51B | $0.21B | 13.68% |
| 2019-06-30 | $1.49B | $0.25B | 16.88% |
| 2019-03-31 | $1.48B | $0.24B | 15.93% |
| 2018-12-31 | $1.47B | $0.23B | 15.49% |
| 2018-09-30 | $1.46B | $0.20B | 13.72% |
| 2018-06-30 | $1.37B | $0.18B | 12.98% |
| 2018-03-31 | $1.29B | $0.16B | 12.43% |
| 2017-12-31 | $1.19B | $0.14B | 11.44% |
| 2017-09-30 | $1.08B | $0.16B | 14.96% |
| 2017-06-30 | $1.05B | $0.18B | 17.00% |
| 2017-03-31 | $1.01B | $0.18B | 17.75% |
| 2016-12-31 | $0.99B | $0.19B | 19.25% |
| 2016-09-30 | $0.98B | $0.17B | 17.81% |
| 2016-06-30 | $0.95B | $0.15B | 15.95% |
| 2016-03-31 | $0.92B | $0.15B | 16.14% |
| 2015-12-31 | $0.88B | $0.14B | 15.97% |
| 2015-09-30 | $0.80B | $0.14B | 17.74% |
| 2015-06-30 | $0.77B | $0.14B | 17.86% |
| 2015-03-31 | $0.79B | $0.13B | 16.31% |
| 2014-12-31 | $0.80B | $0.12B | 14.68% |
| 2014-09-30 | $0.73B | $0.13B | 18.34% |
| 2014-06-30 | $0.74B | $0.09B | 12.30% |
| 2014-03-31 | $0.72B | $0.08B | 11.47% |
| 2013-12-31 | $0.70B | $0.07B | 9.90% |
| 2013-09-30 | $0.83B | $0.04B | 5.18% |
| 2013-06-30 | $0.83B | $0.10B | 11.61% |
| 2013-03-31 | $0.83B | $0.11B | 13.12% |
| 2012-12-31 | $0.83B | $0.13B | 15.66% |
| 2012-09-30 | $0.82B | $0.12B | 14.39% |
| 2012-06-30 | $0.81B | $0.12B | 14.29% |
| 2012-03-31 | $0.80B | $0.11B | 13.58% |
| 2011-12-31 | $0.78B | $0.11B | 13.85% |
| 2011-09-30 | $0.77B | $0.12B | 15.84% |
| 2011-06-30 | $0.76B | $0.13B | 16.82% |
| 2011-03-31 | $0.74B | $0.14B | 18.49% |
| 2010-12-31 | $0.73B | $0.14B | 18.83% |
| 2010-09-30 | $0.72B | $0.14B | 19.92% |
| 2010-06-30 | $0.71B | $0.14B | 19.92% |
| 2010-03-31 | $0.70B | $0.14B | 20.14% |
| 2009-12-31 | $0.68B | $0.14B | 20.50% |
| 2009-09-30 | $0.67B | $0.13B | 19.76% |
| 2009-06-30 | $0.67B | $0.09B | 12.72% |
| 2009-03-31 | $0.66B | $0.08B | 12.75% |
| 2008-12-31 | $0.65B | $0.08B | 12.23% |
| 2008-09-30 | $0.64B | $0.07B | 10.82% |
| 2008-06-30 | $0.61B | $0.11B | 17.82% |
| 2008-03-31 | $0.58B | $0.10B | 17.29% |
| 2007-12-31 | $0.55B | $0.10B | 17.24% |
| 2007-09-30 | $0.52B | $0.10B | 18.92% |
| 2007-06-30 | $0.50B | $0.09B | 18.40% |
| 2007-03-31 | $0.47B | $0.09B | 18.28% |
| 2006-12-31 | $0.42B | $0.08B | 19.09% |
| 2006-09-30 | $0.37B | $0.07B | 19.62% |
| 2006-06-30 | $0.32B | $0.07B | 22.88% |
| 2006-03-31 | $0.29B | $0.07B | 24.22% |
| 2005-12-31 | $0.28B | $0.07B | 24.82% |
| 2005-09-30 | $0.27B | $0.07B | 25.84% |
| 2005-06-30 | $0.26B | $0.04B | 15.56% |
| 2005-03-31 | $0.24B | $0.04B | 16.05% |
| 2004-12-31 | $0.23B | $0.04B | 16.16% |
| 2004-09-30 | $0.23B | $0.04B | 15.49% |
| 2004-06-30 | $0.21B | $0.06B | 26.64% |
| 2004-03-31 | $0.20B | $0.05B | 26.37% |
| 2003-12-31 | $0.19B | $0.05B | 25.81% |
| 2003-09-30 | $0.16B | $0.04B | 25.31% |
| 2003-06-30 | $0.15B | $0.03B | 22.07% |
| 2003-03-31 | $0.13B | $0.03B | 22.66% |
| 2002-12-31 | $0.12B | $0.03B | 23.08% |
| 2002-09-30 | $0.11B | $0.02B | 22.43% |
| 2002-06-30 | $0.10B | $0.03B | 24.75% |
| 2002-03-31 | $0.10B | $0.02B | 23.47% |
| 2001-12-31 | $0.09B | $0.02B | 21.28% |
| 2001-09-30 | $0.09B | $0.00B | 3.37% |
| 2001-06-30 | $0.09B | $0.00B | 1.18% |
| 2001-03-31 | $0.08B | $0.00B | -3.80% |
| 2000-12-31 | $0.07B | $-0.01B | -9.72% |
| 2000-09-30 | $0.07B | $0.00B | 4.62% |
| 2000-06-30 | $0.06B | 0 | 0.00% |
| 2000-03-31 | $0.05B | $-0.01B | -11.32% |
| 1999-12-31 | $0.04B | $-0.01B | -20.93% |
| 1999-09-30 | $0.04B | $-0.01B | -31.43% |
| 1999-06-30 | $0.03B | $-0.01B | -51.85% |
| 1999-03-31 | $0.02B | $-0.01B | -72.22% |
| 1998-12-31 | $0.02B | $-0.01B | -72.22% |
| 1998-09-30 | $0.02B | $-0.01B | -43.75% |
| 1998-06-30 | $0.02B | $0.00B | -12.50% |
| 1998-03-31 | $0.02B | $0.00B | 25.00% |
| 1997-12-31 | $0.01B | $0.01B | 64.29% |
| 1997-09-30 | $0.02B | $0.01B | 46.67% |
| 1997-06-30 | $0.01B | $0.00B | 14.29% |
| 1997-03-31 | $0.01B | $0.00B | 28.57% |
| 1996-12-31 | $0.01B | $0.01B | 35.71% |
| 1996-09-30 | $0.01B | $0.01B | 53.85% |
| 1996-06-30 | $0.01B | $0.01B | 69.23% |
| 1996-03-31 | $0.01B | $0.00B | 36.36% |
| 1995-12-31 | $0.01B | $0.00B | 30.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.222B | $1.635B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |